NATCO Pharma Statistics
Total Valuation
NATCO Pharma has a market cap or net worth of INR 245.65 billion. The enterprise value is 223.17 billion.
Market Cap | 245.65B |
Enterprise Value | 223.17B |
Important Dates
The next estimated earnings date is Tuesday, February 11, 2025.
Earnings Date | Feb 11, 2025 |
Ex-Dividend Date | Nov 27, 2024 |
Share Statistics
NATCO Pharma has 179.11 million shares outstanding. The number of shares has decreased by -1.16% in one year.
Current Share Class | n/a |
Shares Outstanding | 179.11M |
Shares Change (YoY) | -1.16% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 29.87% |
Owned by Institutions (%) | 18.06% |
Float | 80.40M |
Valuation Ratios
The trailing PE ratio is 12.63 and the forward PE ratio is 11.82. NATCO Pharma's PEG ratio is 0.42.
PE Ratio | 12.63 |
Forward PE | 11.82 |
PS Ratio | 5.38 |
PB Ratio | 3.44 |
P/TBV Ratio | 3.55 |
P/FCF Ratio | 18.11 |
P/OCF Ratio | n/a |
PEG Ratio | 0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.39, with an EV/FCF ratio of 16.46.
EV / Earnings | 11.48 |
EV / Sales | 4.89 |
EV / EBITDA | 9.39 |
EV / EBIT | 10.19 |
EV / FCF | 16.46 |
Financial Position
The company has a current ratio of 4.96, with a Debt / Equity ratio of 0.03.
Current Ratio | 4.96 |
Quick Ratio | 3.87 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.09 |
Debt / FCF | 0.15 |
Interest Coverage | 103.34 |
Financial Efficiency
Return on equity (ROE) is 31.23% and return on invested capital (ROIC) is 21.22%.
Return on Equity (ROE) | 31.23% |
Return on Assets (ROA) | 18.89% |
Return on Capital (ROIC) | 21.22% |
Revenue Per Employee | 11.36M |
Profits Per Employee | 4.84M |
Employee Count | 4,016 |
Asset Turnover | 0.63 |
Inventory Turnover | 0.94 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.13% in the last 52 weeks. The beta is 0.51, so NATCO Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.51 |
52-Week Price Change | +73.13% |
50-Day Moving Average | 1,397.83 |
200-Day Moving Average | 1,261.40 |
Relative Strength Index (RSI) | 41.44 |
Average Volume (20 Days) | 692,902 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NATCO Pharma had revenue of INR 45.64 billion and earned 19.45 billion in profits. Earnings per share was 108.58.
Revenue | 45.64B |
Gross Profit | 38.69B |
Operating Income | 21.91B |
Pretax Income | 23.56B |
Net Income | 19.45B |
EBITDA | 23.74B |
EBIT | 21.91B |
Earnings Per Share (EPS) | 108.58 |
Balance Sheet
The company has 24.63 billion in cash and 2.08 billion in debt, giving a net cash position of 22.55 billion or 125.90 per share.
Cash & Cash Equivalents | 24.63B |
Total Debt | 2.08B |
Net Cash | 22.55B |
Net Cash Per Share | 125.90 |
Equity (Book Value) | 71.57B |
Book Value Per Share | 399.14 |
Working Capital | 39.93B |
Cash Flow
In the last 12 months, operating cash flow was 17.16 billion and capital expenditures -3.60 billion, giving a free cash flow of 13.56 billion.
Operating Cash Flow | 17.16B |
Capital Expenditures | -3.60B |
Free Cash Flow | 13.56B |
FCF Per Share | 75.72 |
Margins
Gross margin is 84.78%, with operating and profit margins of 48.01% and 42.61%.
Gross Margin | 84.78% |
Operating Margin | 48.01% |
Pretax Margin | 51.62% |
Profit Margin | 42.61% |
EBITDA Margin | 52.01% |
EBIT Margin | 48.01% |
FCF Margin | 29.72% |
Dividends & Yields
This stock pays an annual dividend of 5.75, which amounts to a dividend yield of 0.42%.
Dividend Per Share | 5.75 |
Dividend Yield | 0.42% |
Dividend Growth (YoY) | -45.45% |
Years of Dividend Growth | 2 |
Payout Ratio | 5.10% |
Buyback Yield | 1.16% |
Shareholder Yield | 1.57% |
Earnings Yield | 7.92% |
FCF Yield | 5.52% |
Stock Splits
The last stock split was on November 26, 2015. It was a forward split with a ratio of 5.
Last Split Date | Nov 26, 2015 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |